Free Trial
NASDAQ:ZIVO

ZIVO Bioscience (ZIVO) Stock Price, News & Analysis

ZIVO Bioscience logo
$11.05 -0.16 (-1.43%)
As of 11:25 AM Eastern

About ZIVO Bioscience Stock (NASDAQ:ZIVO)

Key Stats

Today's Range
$11.05
$11.05
50-Day Range
$11.21
$18.72
52-Week Range
$5.80
$22.15
Volume
187 shs
Average Volume
957 shs
Market Capitalization
$42.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZIVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZIVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

ZIVO Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

ZIVO Stock Analysis - Frequently Asked Questions

ZIVO Bioscience's stock was trading at $21.50 at the beginning of 2025. Since then, ZIVO shares have decreased by 48.6% and is now trading at $11.05.

ZIVO Bioscience, Inc. (NASDAQ:ZIVO) issued its quarterly earnings results on Monday, May, 11th. The biotechnology company reported ($0.06) EPS for the quarter. The biotechnology company earned $0.02 million during the quarter.

ZIVO Bioscience's stock reverse split before market open on Friday, October 27th 2023.The 1-6 reverse split was announced on Friday, October 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of ZIVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ZIVO Bioscience investors own include Canopy Growth (CGC), Meta Platforms (META), OPKO Health (OPK), Johnson & Johnson (JNJ), ACADIA Pharmaceuticals (ACAD), Aravive (ARAV) and Alibaba Group (BABA).

Company Calendar

Last Earnings
5/11/2020
Today
7/25/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ZIVO
Previous Symbol
OTCMKTS:HEPI
CIK
1101026
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.93)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.78 million
Net Margins
N/A
Pretax Margin
-17,113.75%
Return on Equity
N/A
Return on Assets
-2,240.92%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.17
Quick Ratio
0.17

Sales & Book Value

Annual Sales
$15.85 thousand
Price / Sales
2,661.06
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.81) per share
Price / Book
-13.64

Miscellaneous

Outstanding Shares
3,817,000
Free Float
2,911,000
Market Cap
$42.18 million
Optionable
Not Optionable
Beta
-0.06

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:ZIVO) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners